Shernan Holtan is a Hematology physician. OpenAlex indexes 468 publications with 7,102 citations (h-index 41); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
909 Fulton St SE
Minneapolis, MN 554554800
Telephone
612-625-3600Provider last certified this registry record 18 Jan 2024.
Clinical trials
- Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Roswell Park Cancer Institute
- Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
Sponsor: Masonic Cancer Center, University of Minnesota
- Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
Sponsor: Masonic Cancer Center, University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20255 payments$21,446openpaymentsdata.cms.gov ↗
- Kite Pharma, Inc.Program year20252 payments
- National Marrow Donor ProgramProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2022–2022 per NIH RePORTER. The latest:
- ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML
University of Minnesota
FY2022$184,800UG1HL069290
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
New England Journal of Medicine
2023 - Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review
Bone Marrow Transplantation
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Tait Shanafelt, MD
Palo Alto University
Robert Bast, MD
The University of Texas MD Anderson Cancer Center
Thomas Witzig, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”